Digest Network Come funziona
Network
/
Società
De
Non verificato

DelveInsight Business Research, LLP

Di cosa scriviamo

BiologiaEconomiaFarmaceuticaSanitàScienza

213 comunicati stampa

Guarda tutti i comunicati
29/05/2025
Farmaceutica
Sanità
INBRIJA Positioned for Stronger Market Penetration as Demand Grows for Inhaled Parkinson's Therapy| DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
1,00
0
29/05/2025
Farmaceutica
Sanità
B-Cell Inhibitors Market Poised for Significant Advances During the Forecast Period (2025-2034) Across 7MM Due to Novel Drug Launches | DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
1,00
0
29/05/2025
Farmaceutica
Sanità
Anal Cancer Market Heats Up Following Incyte's Zynyz Greenlight | DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
1,00
0
28/05/2025
Farmaceutica
Sanità
Biologia
Merck's WELIREG Entry Brings New Momentum to Pheochromocytomas and Paragangliomas Therapeutics Market | DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
1,00
0
27/05/2025
Farmaceutica
Sanità
FILSPARI to Transform Kidney Disease Care with Its Revolutionary Treatment Approach | DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
1,00
0
26/05/2025
Farmaceutica
Sanità
Rett Syndrome Market Sees Momentum with Novel Gene and Protein-Targeted Therapies | DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
1,00
0
22/05/2025
Farmaceutica
Sanità
Biologia
Johnson & Johnson's IMAAVY Gets FDA Approval, Taking on Top Players in Myasthenia Gravis Market | DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
1,00
0
22/05/2025
Farmaceutica
Sanità
Biologia
ZEVASKYN Approval Positions Abeona as Emerging Player in Dystrophic Epidermolysis Bullosa Market | DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
1,00
0
21/05/2025
Farmaceutica
Sanità
Migraine Market Enters New Era Following Satsuma Pharmaceuticals' ATZUMI and Amneal Pharmaceuticals' BREKIYA Regulatory Approval | DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
1,00
0
20/05/2025
Farmaceutica
Sanità
MAC Lung Disease Market Poised for Growth Across the 7MM During the Forecast Period (2025-2034) Amid Rising Prevalence and New Therapeutic Solutions | DelveInsight
Fonte
DelveInsight Business Research, LLP
Emittente
PR News Wire
1,00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0